Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001193125-25-246866·Cooperatieve Gilde Healthcare IV U.A.
Schedule 13D ownership disclosure
LAVA THERAPEUTICS NV
Common shares, Euro 0.12 nominal value per share · CUSIP: N51517105
Event date: 2025-10-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Cooperatieve Gilde Healthcare IV U.A.Reported CIK 0001756335
Shares: 1,014,751 · Class: 3.9%
- Gilde Healthcare IV Management B.V.Reported CIK 0001757508
Shares: 1,014,751 · Class: 3.9%
- Gilde Healthcare Holding B.V.Reported CIK 0001420106
Shares: 1,014,751 · Class: 3.9%
- Manapouri B.V.
Shares: 1,014,751 · Class: 3.9%
- Martemanshurk B.V.
Shares: 1,014,751 · Class: 3.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-246866
- Form type
- SCHEDULE 13D/A
- Filer
- Cooperatieve Gilde Healthcare IV U.A.
- CIK
- CIK 1756335
- Filed
- Oct 22, 2025
- Reporting period
- Oct 20, 2025
- Description
- Schedule 13D beneficial ownership